Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis in children.

M Tardieu1, Y Mikaeloff

  • 1Service de Neurologie Pédiatrique and INSERM E0109, Hôpital Bicêtre, Faculte de Medecine Paris-Sud, 94276 Le Kremlin Bicetre, Cedex, France. marc.tardieu@kb.u-psud.fr

International MS Journal
|July 29, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acquired cutaneous pseudoxanthoma elasticum progressing after chronic liver transplant rejection.

Annales de dermatologie et de venereologie·2025
Same author

Management of Tinea Capitis in children under 10 kg : Results from a French multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2025
Same author

Homocystinuria in a 14-year-old girl with neurodevelopmental delay.

Journal francais d'ophtalmologie·2024
Same author

Lupus anticoagulant laboratory diagnosis by applying the 2020 ISTH-SSC guidelines.

Thrombosis research·2023
Same author

Is off-label thrombolysis safe and effective in a real-life primary stroke center? A retrospective analysis of data from a 5-year prospective database.

Revue neurologique·2022
Same author

Prolonged impact of the COVID-19 pandemic on self-harm hospitalizations in France: A nationwide retrospective observational study.

European psychiatry : the journal of the Association of European Psychiatrists·2022
Same journal

American academy of neurology annual meeting.

International MS journal·2011
Same journal

Tumour Necrosis Factor Neutralization in MS: A Cautionary Tale.

International MS journal·2011
Same journal

The clinical usefulness of routine MRI assessment.

International MS journal·2011
Same journal

Acute Psychosis as the Initial Presentation of MS: A Case Report.

International MS journal·2011
Same journal

Russell Brains Review of MS.

International MS journal·2011
Same journal

Epstein-Barr Virus and MS:Causality or Association?

International MS journal·2011
See all related articles

Pediatric multiple sclerosis (MS) diagnosis is challenging, especially in children under 10. Factors like younger age and polysymptomatic presentation may indicate a lower MS risk, with outcomes potentially better than in adults.

Area of Science:

  • Pediatric Neurology
  • Neuroimmunology
  • Demyelinating Diseases

Background:

  • Multiple sclerosis (MS) can manifest in childhood, presenting diagnostic challenges.
  • Initial demyelinating events in children may mimic other conditions like acute disseminated encephalomyelitis or CNS vasculitis.
  • Early diagnosis is crucial for appropriate management and understanding disease trajectory.

Purpose of the Study:

  • To review the diagnostic challenges of pediatric multiple sclerosis (MS).
  • To identify factors influencing the risk of developing MS in children.
  • To discuss the prognosis and treatment considerations for MS in pediatric populations.

Main Methods:

  • Review of existing literature on pediatric multiple sclerosis.
  • Analysis of clinical presentation and diagnostic criteria for childhood MS.

Related Experiment Videos

  • Evaluation of prognostic indicators and treatment outcomes in pediatric MS cases.

    • Main Results:

    • The risk of developing MS in children is lower with younger age (<10 years), altered consciousness, polysymptomatic presentation, and large white matter lesions.
    • Pediatric MS may have a slightly better prognosis compared to adult-onset MS.
    • Methylprednisolone is the primary initial treatment; data on beta-interferon efficacy in children is limited.

    Conclusions:

    • Diagnosing MS in children requires careful consideration of differential diagnoses.
    • Certain clinical and radiological features can help stratify MS risk in pediatric patients.
    • Further research is needed on long-term treatment outcomes, particularly for disease-modifying therapies like beta-interferon, in children with MS.